Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

131.28
Delayed Data
As of 4:00pm ET
 -4.35 / -3.21%
Today’s Change
117.64
Today|||52-Week Range
189.00
+3.05%
Year-to-Date
Zogenix (ZGNX) Stock Surges on Acquisition Offer From UCB
Jan 20 / Zacks.com - Paid Partner Content
2 Stocks to Buy No Matter What Happens in 2022
Jan 14 / MotleyFool.com - Paid Partner Content
Can Jazz (JAZZ) Climb 41% to Reach the Level Wall Street Analysts Expect?
Jan 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close135.63
Today’s open133.66
Day’s range129.79 - 133.82
Volume24,868
Average volume (3 months)635,767
Market cap$8.4B
Data as of 4:00pm ET, 01/25/2022

Growth & Valuation

Earnings growth (last year)-53.56%
Earnings growth (this year)+25.97%
Earnings growth (next 5 years)+11.30%
Revenue growth (last year)+9.34%
P/E ratioNM
Price/Sales3.95
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
BHCValeant Pharmaceutic...-0.29-1.18%
BHVNBiohaven Pharmaceuti...-2.46-2.07%
UTHRUnited Therapeutics ...-2.88-1.42%
EVOEvotec SE-0.40-2.01%
Data as of 4:00pm ET, 01/25/2022

Financials

Next reporting dateMarch 1, 2022
EPS forecast (this quarter)$3.68
Annual revenue (last year)$2.4B
Annual profit (last year)$238.6M
Net profit margin10.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts